is semaglutide off the shortage list GLP-1 Drugs: FDA Removes from Drug FDA declares semaglutide (Ozempic/Wegovy) shortage
Description
Shifting Trends in the Indication of Glucagon-like Peptide-1 Receptor Agonist Prescriptions: A Nationwide Analysis
doi: 10.1038/533452a 51 NicholsJDOliMKKendallWLBoomerGS
( 7 ) However, these side effects typically subside over time as the body gets used to the new medication
A GLP-1 medication helps regulate appetite, digestion, and blood sugar levels
Gastrointestinal side effects occur in 6070% of patients at higher doses but typically resolve within 48 weeks of dose stabilization, comparable to tirzepatide but more frequent than semaglutide
